investerare
Med en snabbt växande verksamhet i Europa och planer på en framtida lansering i USA är Sedana Medical väl positionerat för framtiden.
Vi är på god väg mot vår vision att göra inhalationssedering till en standardbehandling inom intensivvården.
- Johan Spetz
- CFO och chef för Investor Relations
- ir@sedanamedical.com
Aktie
Pressmeddelanden
2026
2026-07-03 13:00
Invitation to presentation of Sedana Medical’s interim report for the second quarter 2026
Sedana Medical AB (publ) plans to present its interim report for the second quarter of 2026 on Friday July 17 at 13:30 CET. According to the financial...
2026-06-17 08:00
Mikael Haag takes office as new CFO of Sedana Medical
Sedana Medical AB (publ) today announces that Mikael Haag takes office as Chief Financial Officer (CFO) and member of the Executive Management Team, effective...
2026-06-17 07:30
Sedana Medical submits New Drug Application to the U.S. FDA for inhaled sedation in the ICU
Sedana Medical AB (publ) today announces that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the drug-device...
Finansiella rapporter
Finansiell kalender
Senaste presentationen
No presentations found.